ATE70449T1 - Zusammensetzungen von katecholischen butanen mit zink. - Google Patents

Zusammensetzungen von katecholischen butanen mit zink.

Info

Publication number
ATE70449T1
ATE70449T1 AT87907401T AT87907401T ATE70449T1 AT E70449 T1 ATE70449 T1 AT E70449T1 AT 87907401 T AT87907401 T AT 87907401T AT 87907401 T AT87907401 T AT 87907401T AT E70449 T1 ATE70449 T1 AT E70449T1
Authority
AT
Austria
Prior art keywords
zinc
compositions
catecholic
catecholic butanes
new compositions
Prior art date
Application number
AT87907401T
Other languages
English (en)
Inventor
Russell T Jordan
Original Assignee
Chemex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemex Pharmaceuticals Inc filed Critical Chemex Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE70449T1 publication Critical patent/ATE70449T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT87907401T 1986-10-28 1987-10-27 Zusammensetzungen von katecholischen butanen mit zink. ATE70449T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/924,620 US4880637A (en) 1985-02-11 1986-10-28 Compositions of catecholic butanes with zinc
PCT/US1987/002868 WO1988003026A1 (en) 1986-10-28 1987-10-27 Compositions of catecholic butanes with zinc
EP87907401A EP0288534B1 (de) 1986-10-28 1987-10-27 Zusammensetzungen von katecholischen butanen mit zink

Publications (1)

Publication Number Publication Date
ATE70449T1 true ATE70449T1 (de) 1992-01-15

Family

ID=25450444

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87907401T ATE70449T1 (de) 1986-10-28 1987-10-27 Zusammensetzungen von katecholischen butanen mit zink.

Country Status (8)

Country Link
US (1) US4880637A (de)
EP (1) EP0288534B1 (de)
JP (1) JPH01501794A (de)
KR (1) KR880701556A (de)
AT (1) ATE70449T1 (de)
AU (1) AU616641B2 (de)
DE (1) DE3775387D1 (de)
WO (1) WO1988003026A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0290442A4 (de) * 1986-11-19 1990-07-03 Chemex Pharmaceuticals Inc Arzneimittelzubereitungen und gemische daraus, organische zusammensetzungen und metallsalze.
US6046243A (en) * 1993-02-12 2000-04-04 Bernard Technologies, Inc. Compositions for sustained release of a gas
US5409690A (en) * 1993-06-23 1995-04-25 Chemex Pharmaceuticals, Inc. Treatment of multidrug resistant diseases in cancer cell by potentiating with masoprocol
AU698313B2 (en) * 1994-03-14 1998-10-29 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents
US6365787B1 (en) * 1994-09-30 2002-04-02 The Johns Hopkins University Compounds for the suppression of HIV TAT transactivation
US5837252A (en) * 1996-07-01 1998-11-17 Larreacorp, Ltd. Nontoxic extract of Larrea tridentata and method of making same
US5827898A (en) * 1996-10-07 1998-10-27 Shaman Pharmaceuticals, Inc. Use of bisphenolic compounds to treat type II diabetes
FR2785804B1 (fr) * 1998-11-17 2002-10-18 Sederma Sa Compositions a usage cosmetique ou dermopharmaceutique contenant un extrait de larrea divaricata ou de larrea tridentata pour ralentir le vieillissement cutane
US6787573B2 (en) * 1999-07-02 2004-09-07 Universiteit Utrecht Antiviral therapy
US6608108B2 (en) * 1999-10-15 2003-08-19 Johns Hopkins University Method for treatment of tumors using nordihydroguaiaretic acid derivatives
US6214874B1 (en) * 1999-10-15 2001-04-10 John Hopkins University Treatment of HPV induced cancer using in situ application of two nordihydroguiaretic acid derivatives, tetramethyl NDGA M4N and tetraglycinal NDGA G4N
WO2004112695A2 (en) * 2003-05-20 2004-12-29 Erimos Pharmaceutical Llc Methods and compositions for delivery of catecholic butanes for treatment of obesity
US7728036B2 (en) * 2003-05-20 2010-06-01 Erimos Pharmaceuticals, Llc Methods for delivery of catecholic butanes for treatment of tumors
US20060141029A1 (en) * 2003-05-20 2006-06-29 Erimos Pharmaceuticals Llc Methods and compositions for delivery of catecholic butanes for treatment of diseases
US7420105B2 (en) 2004-03-11 2008-09-02 Carlsberg A/S Barley for production of flavor-stable beverage
CN100440843C (zh) * 2004-05-12 2008-12-03 华为技术有限公司 一种环网及其业务实现方法
JP5128277B2 (ja) 2004-05-28 2013-01-23 ユニジェン・インコーポレーテッド 二核酵素の強力な阻害剤としてのジアリールアルカン類
US8440648B2 (en) * 2004-07-20 2013-05-14 Erimos Pharmaceuticals Llc Methods and compositions for treatment of intraepithelial neoplasia
AU2006208108A1 (en) * 2005-01-27 2006-08-03 Erimos Pharmaceuticals Llc Oral formulations for delivery of catecholic butanes including NDGA compounds
CN101150955B (zh) * 2005-01-27 2013-04-17 埃里莫斯医药品有限公司 递送包括ndga化合物的儿茶酚丁烷的口服制剂
EP1996174A2 (de) * 2006-02-23 2008-12-03 Erimos Pharmaceuticals LLC Verfahren zur behandlung von influenza-virusinfektionen
US20070212331A1 (en) * 2006-03-07 2007-09-13 Baldassare Joseph J Methods and compositions for selectively killing cells
US9067875B2 (en) 2006-10-02 2015-06-30 Erimos Pharmaceuticals Llc Tetra-substituted NDGA derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
CN101547689B (zh) * 2006-10-02 2014-02-26 埃里莫斯医药品有限公司 通过醚键和氨基甲酸酯键四取代的ndga衍生物、它们的合成方法和药学用途
US7597914B1 (en) * 2007-10-02 2009-10-06 Allen Jay Cohen Ala-septic pre-cancerous liquid dissolving solution and method
US8153171B1 (en) * 2007-10-02 2012-04-10 Allen Jay Cohen Solution for dissolving pre-melanoma lesions and melanoma lesions including psoriasis, herpes simplex lesions and eczema lesions
KR101661608B1 (ko) 2008-07-21 2016-09-30 유니젠, 인크. 일련의 피부-화이트닝(라이트닝) 화합물
WO2012129260A1 (en) 2011-03-24 2012-09-27 Unigen, Inc. Compounds and methods for preparation of diarylpropanes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404146A (en) * 1980-12-17 1983-09-13 Biosystems Research Inc. Metal oxyalkylates and method of making same
US4774229A (en) * 1982-04-05 1988-09-27 Chemex Pharmaceuticals, Inc. Modification of plant extracts from zygophyllaceae and pharmaceutical use therefor
AU6330486A (en) * 1986-08-25 1988-03-24 Chemex Pharmaceuticals Inc. Pharmacologically active compositions of catecholic butanes with zinc
WO1988001509A1 (en) * 1986-08-25 1988-03-10 Chemex Pharmaceuticals, Inc. Pharmacologically active compositions of catecholic butanes with zinc
AU6737987A (en) * 1986-11-19 1988-06-16 Chemex Pharmaceuticals Inc. Pharmacologically active compositions of catecholic butanes with zinc

Also Published As

Publication number Publication date
US4880637A (en) 1989-11-14
EP0288534A4 (de) 1989-02-23
EP0288534A1 (de) 1988-11-02
EP0288534B1 (de) 1991-12-18
DE3775387D1 (de) 1992-01-30
JPH01501794A (ja) 1989-06-22
KR880701556A (ko) 1988-11-03
AU8172487A (en) 1988-05-25
WO1988003026A1 (en) 1988-05-05
AU616641B2 (en) 1991-11-07

Similar Documents

Publication Publication Date Title
ATE70449T1 (de) Zusammensetzungen von katecholischen butanen mit zink.
ES2020011A6 (es) Metodo de sintesis de composiciones que comprenden al menos un butano fenolico.
FR2653336B1 (fr) Composition pharmaceutique et cosmetiques depigmentantes a base d'acide cafeique.
DE69621012D1 (de) VERWENDUNG VON NSAIDs ZUR BEHANDLUNG VON PLATTENEPITHELKARZINOM DER MUNDHÖHLE UND KEHLKOPF
AU471598B2 (en) 2-amidazolin 2-ylamino substituted quinoxaline and quinazolines as antihypertensive agents
KR850005272A (ko) 피부 보호 조성물의 제조방법
ATE68702T1 (de) Zusammensetzungen zur behandlung von viralen und krebsartigen hautverletzungen und dergleichen.
IT7920131A0 (it) Impiego di polimeri reticolati per aumentare la viscosita' di preparati cosmetici, farmaceutici e tecnici.
MY100789A (en) Hair cosmetic composition
SE7611379L (sv) Antihypertensiva medel
DE3787356D1 (de) Expression von höheren eukaryotischen genen in aspergillus.
MX9306960A (es) Composiciones de extracto de corteza de roble, compositiones sinteticasrelacionadas, y metodo para su utilizacion.
JPS57185208A (en) Skin cosmetic
ATE16489T1 (de) Aroylimidazolone.
KR910007536A (ko) 외용 피부 제제
DE3780618D1 (de) Verwendung von buspiron zur verbesserung des kurzzeitgedaechtnisses.
ES418227A1 (es) Un procedimiento para producir particulas funcionales fina-mente divididas.
ATE52911T1 (de) Topische anwendung des 3-phenylacetylamino-2,6piperidindionszur behandlung von hautfalten und hyperpigmentierung.
SE8703210D0 (sv) Hudvardskompositioner med keratolytisk och antiinflammatorisk aktivitet
IT1148273B (it) Composizione liquida per trattamento migliorativo di tessuti la quale contiene amido vegetale gelatinizzato,tensioattivo ed elettrolita
ES2039578T3 (es) Procedimiento para producir mercapto-acilaminoacidos antihipertensivos.
DE3581979D1 (de) Elektronenstrahlbehandlung zum erhoehen des haftvermoegens von polyesterfilmen.
FR2401187A1 (fr) Nouveaux oligomeres tensio-actifs sequences, procede pour les preparer et compositions les contenant
ATE111348T1 (de) Kosmetische zusammensetzung auf der basis von chromo-carboxylaten.
ATE79255T1 (de) Wirkstoffe zur verhuetung von tumormetastasen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee